Phase 2 Mild to moderate Alzheimer's disease Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
Mild to moderate Alzheimer's disease
Xuanwu Hospital, Beijing33 enrolled1 locationNCT07457125
Recruiting
Phase 2
Open Label Extension Study to Evaluate the Safety, Tolerability and Cognitive Effects of VEL015 (Sodium Selenate) in Patients with Alzheimer’s Disease
Mild to moderate Alzheimer's disease
Velacor Therapeutics Pty Ltd40 enrolled3 locationsACTRN12613000170729